Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update
New sites accelerate registrational study enrollment - 15 patients have been enrolled in the NEPHRO study which remains on track with completion projected by the end of the year Cash and cash equiv...
How might the sentiment score of 35 influence short‑term trader sentiment and volatility in the stock?
What is the market’s reaction to the conference call, and are there any red‑flag comments from management regarding risks or delays?
How does TRIA’s valuation metrics (e.g., P/E, EV/EBITDA) look after this earnings release relative to peers in the nephrology biotech space?
27 days ago